A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™ (clinicaltrials.gov) - Oct 22, 2026 - P1 | N=36 | Completed | Sponsor: University of Oxford | Active, not recruiting ➔ Completed | Trial completion date: Jun 2027 ➔ Sep 2026 | Trial primary completion date: Jun 2026 ➔ Sep 2026
Trial completion • Trial completion date • Trial primary completion date • Infectious Disease • Malaria
|